A new paradigm for tumor immune escape: β-catenin-driven immune exclusion
about
Update on immune checkpoint inhibitors in gynecological cancersHuman melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk.Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.Targeting the PD-1 pathway in pediatric solid tumors and brain tumors.Naturally occurring compounds acting as potent anti-metastatic agents and their suppressing effects on Hedgehog and WNT/β-catenin signalling pathways.Wnt/beta-catenin pathway: modulating anticancer immune response.Rho GTPase effectors and NAD metabolism in cancer immune suppression.Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients.Overexpression of adhesion molecules and barrier molecules is associated with differential infiltration of immune cells in non-small cell lung cancer.Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC).β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models.Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced Melanoma.β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion.Immune oncology, immune responsiveness and the theory of everything.Hedgehog Signaling in Lung Cancer: From Oncogenesis to Cancer Treatment Resistance
P2860
Q28076497-C9576ED5-1A7E-438F-952C-7D7524EC6476Q30274920-DC70CA0F-2C4A-480D-AD8B-37F63C51FC1DQ30276128-62C8E617-5482-4F6A-A617-F1E4371F6955Q38819982-EF7CBFD9-604C-4662-9805-9DBB19929DBCQ38964713-C3FBEC7F-09B0-44F3-B04B-C35D9DC05B14Q39286193-2A27ED84-5D81-4942-8FA1-92EC9DF7CA39Q45974765-0589136F-B99F-4895-A949-4B77ED85461DQ48703829-9FE2A398-A4C7-4448-BD36-75C38B0043CBQ49166013-E677DD12-8D7B-4AC1-B23B-7DB1DBB4D30EQ49243761-82C83C34-4908-4C1D-81DB-222A3F397344Q49547317-79370E79-2ABB-45BC-9932-68CC0A838CF7Q50736853-EB47AEE5-5024-451F-9978-13883A096756Q55312964-05F521B2-8918-4D75-B9F2-F82603CE66B6Q55487467-634235B5-77D2-411D-ACD8-87C5CE4B0E12Q58715973-F18CF143-756A-41B4-93AE-E28516EB3EB2
P2860
A new paradigm for tumor immune escape: β-catenin-driven immune exclusion
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A new paradigm for tumor immune escape: β-catenin-driven immune exclusion
@en
type
label
A new paradigm for tumor immune escape: β-catenin-driven immune exclusion
@en
prefLabel
A new paradigm for tumor immune escape: β-catenin-driven immune exclusion
@en
P2860
P1476
A new paradigm for tumor immune escape: β-catenin-driven immune exclusion
@en
P2093
Stefani Spranger
Thomas F Gajewski
P2860
P2888
P356
10.1186/S40425-015-0089-6
P577
2015-09-15T00:00:00Z
P5875
P6179
1022474219